Abimbola Oduguwa, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 6200 Beach Channel Dr, Arverne, NY 11692 Phone: 718-945-7150 |
Dr. Roselia Guillen-santana, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 6200 Beach Channel Dr, Arverne, NY 11692 Phone: 718-945-7150 |
Dr. Betty A Chua, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6200 Beach Channel Dr, Arverne, NY 11692 Phone: 718-945-7150 |
Dr. Sanga Bunyavanich, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 6200 Beach Channel Dr, Arverne, NY 11692 Phone: 718-945-7150 Fax: 718-663-6133 |
News Archive
The Medicare program could be paying multiple times for prescription drugs for hospice beneficiaries, a new federal report suggests.
Sermo, the world's largest online community for physicians, today announced its weekly hot topic. More than 500 physicians participated in a Sermo post "FTC - Refusal to accept Medicare pricing = Price Fixing." The discussion focuses on a complaint from the FTC that the Roaring Fork Valley Physicians IPA, by refusing to accept Medicare price controls, violated anti-trust laws. The announcement prompted strong reaction among many physicians who argue they should be able to accept or decline payment terms, like any other profession.
Most organisms need iron to survive, but too much iron is toxic, and can cause fatal organ failure. The same is true inside cells, where iron balance must also be maintained. In a study published today in Cell Metabolism, scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, have discovered that a group of proteins named IRPs ensure that this iron balance is kept and as such are essential for cell survival. More specifically, they found that IRPs are required for the functioning of mitochondria, the cell's energy factories.
Accumetrics, Inc., developer of the VerifyNow System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, today announced that patients with high platelet reactivity, i.e. high PRU values as measured by the Accumetrics VerifyNow P2Y12 Test, exhibited an approximately four times higher rate of stent thrombosis than patients without high platelet reactivity, as seen in the ADAPT-DES registry.
According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, despite the rising popularity of drug-eluting stents (DES) across Latin America, bare-metal stents (BMS) will continue to represent a significant portion of the overall coronary stent market through 2014. This trend is especially evident in Brazil, where the public healthcare system does not provide any reimbursement for DES procedures.
› Verified 9 days ago